malaria

The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study comes to an alarming conclusion.

The Central African Republic is the first country to receive thousands of doses of a new malaria vaccine recommended by the World Health Organization last October.

The country's toll makes up nearly a third of the world's 619,000 malaria deaths each year. Now Nigeria has approved a new vaccine. Will it get into the arms of those who need it most?

After 20 years without a reported local case, malaria is spreading again in the United States. Four people in Florida and one in Texas caught the disease locally, according to the CDC.

Four of the cases were found in Florida, while the fifth was logged in Texas, according to the Centers for Disease Control and Prevention.

Volunteers for the trial put an arm over a box with hundreds of mosquitoes carrying a genetically modified malaria parasite. Here's why they did it that way — and why the trial holds promise.

Resistance to the drug artemisinin was confirmed in Africa. Without better surveillance, experts say it is hard to track the threat.

The vaccine is called Mosquirix, a nod to the mosquitos that spread the malaria parasite when they bite.

It's also the first vaccine against a parasitic disease in humans. But there are issues to consider, from its rate of effectiveness to the dosage schedule.

Did you even know the U.S. has a malaria czar? Who himself had malaria as a kid? We interview Dr. Raj Panjabi, newly appointed by President Joe Biden.